Stockscreener 앱 받기
8.52
2.77%
0.23
Day One Biopharmaceuticals Inc 주식(DAWN)의 최신 뉴스
Is Day One Biopharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Profit Market Tips - earlytimes.in
Day One Biopharmaceuticals unveils promising Phase 2 trial data - Traders Union
Will Day One Biopharmaceuticals Inc. stock maintain momentum in 2025Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
Can Day One Biopharmaceuticals Inc. stock maintain growth trajectoryWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade - MSN
Can Day One Biopharmaceuticals Inc. stock deliver consistent earnings growthJuly 2025 Breakouts & Real-Time Market Trend Scan - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersAnalyst Upgrade & Safe Entry Zone Tips - newser.com
Day One Biopharmaceuticals, Inc.Common Stock (NQ: DAWN - FinancialContent
Day one biopharma gen counsel sells $38k in shares By Investing.com - Investing.com South Africa
Can Day One Biopharmaceuticals Inc. rally from current levelsQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Index Update & Safe Swing Trade Setup Alerts - newser.com
Day One Biopharmaceuticals Inc. stock volume spike explainedTrade Signal Summary & Weekly High Conviction Trade Ideas - newser.com
Day one biopharma gen counsel sells $38k in shares - Investing.com India
[Form 4] Day One Biopharmaceuticals, Inc. Insider Trading Activity - Stock Titan
COO York II Acquires 12,813 Of Day One Biopharmaceuticals Inc [DAWN] - TradingView
Day One Biopharmaceuticals CEO Jeremy Bender Sells Shares - TradingView
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundTake Profit & Daily Profit Focused Stock Screening - newser.com
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more - MSN
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Avadel deems Lundbeck offer ‘superior’ to Alkermes’: Deals Report - BioCentury
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in $285 Million Deal - Global Legal Chronicle
Officer Merendino Files To Sell 3,726 Of Day One Biopharmaceuticals Inc [DAWN] - TradingView
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
(DAWN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Will Day One Biopharmaceuticals Inc. stock maintain growth storyJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options dataMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - newser.com
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal - Stocktwits
Day One Biopharmaceuticals Inc. stock outlook for YEARLayoff News & Real-Time Volume Analysis Alerts - newser.com
Day One to buy Mersana Therapeutics for $25/share upfront - MSN
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more (BX:NYSE) - Seeking Alpha
Mersana Therapeutics Faces High Stakes with Potential Day One Biopharmaceuticals Merger Delays - MSN
1.38%
1.42%
자본화:
|
볼륨(24시간):